Search
for
Sort by
Research 811–840 of 1000+
- Finasteride drug safety alert
- Risk of muscular adverse effects with finasteride
- MP13-07 FINASTERIDE MONOTHERAPY BEFORE TURP: SIGNIFICANT IMPROVEMENT IN EARLY POSTOPERATIVE QUALITY OF LIFE
- No increased risk of CV events with dutasteride vs finasteride
- Dutasteride, finasteride: no increased risk of ED
- 102 Methylation of CpG islands in promoter of type 2 5-α reductase and implications of finasteride resistance for BPH therapy
- No clear link between finasteride and suicidality
- Faculty Opinions recommendation of Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- Finasteride
- PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY
- Luncheon Symposium (LS) : Update on the efficacy and safety of dutasteride in the management of androgenetic alopecia
- Sponsored Lecture 3 : Updates on 5 alpha-rers(5ARIs) for the treatment of male pattern hair loss(MPHL)
- Urinary symptoms in patients with androgenetic alopecia
- Dutasteride for Androgenetic Alopecia—Words of Caution
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Does a male polycystic ovarian syndrome equivalent exist?
- Safety aspects of androgen treatment with 5α-dihydrotestosterone
- Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5α-reductases 1 and 2
- Inappropriate Sexual Behaviors in Patients with Vascular Dementia: Possible Response to Finasteride
- Role of ACE2 polymorphism in COVID-19: impact of age
- Synthesis and bioactivity of new Finasteride conjugate
- Clinical benefits and adverse effects of genetically-elevated free testosterone levels: a Mendelian randomization analysis
- Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery
- Finasteride Induced Cerebral Venous Thrombosis
- High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma
- Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms”
- Structural basis for the catalysis and inhibition of human steroid 5α‐reductase 2
- PD14-05 ECONOMIC IMPLICATIONS OF UROLOGIST PRESCRIPTION PRACTICES AMONG MEDICARE PART D BENEFICIARIES
- Saw Palmetto
- 利用地面光達點雲建置三維房屋模型;Reconstructing 3D Building Model from Terrestrial LiDAR Point Cloud